Representational image
Pfizer announced Friday (Jan 22) that it will provide up to 40 million of its Covid-19 vaccine doses to poorer countries on a non-profit basis, through the globally-pooled Covax facility.
While dozens of the world’s richer countries have begun their vaccination campaigns in a bid to curb the pandemic, coronavirus jabs have been few and far between in the world’s poorer nations.
Covax – the globally-pooled coronavirus vaccine procurement and equitable distribution effort, aimed at ensuring that lower-income countries get hold of doses too – is hoping to ship its first deliveries in February.
Covax is co-led by the World Health Organization and Gavi, the Vaccine Alliance. The Pfizer-BioNTech vaccine is the only one so far to have received emergency use approval from the WHO.
Developing countries should have “the same access to vaccines as the rest of the world”, Pfizer chairman Albert Bourla told a virtual press conference.
“We will provide the vaccine to Covax for these countries at a not-for-profit basis.
“We are proud to have this opportunity to provide doses that will support Covax’s efforts towards vaccinating health care workers at high risk of exposure in developing countries, and other vulnerable populations.”
– Source: News websites
